Screener
Bruker BRKR R&D
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Bruker’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 416.0 | 357.9 | 795.8 | 749.1 |
| Operating expenses: | ||||
| Selling, general and administrative | 238.9 | 231.4 | 481.0 | 456.8 |
| Research and development | 94.3 | 100.2 | 195.6 | 197.3 |
| Goodwill impairment charge | 134.9 | — | 134.9 | — |
| Other charges, net | 13.2 | 14.4 | 39.4 | 51.3 |
| Total operating expenses | 481.3 | 346.0 | 850.9 | 705.4 |
| Operating (loss) income | (65.3) | 11.9 | (55.1) | 43.7 |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Bruker's R&D?
- Bruker (BRKR) reported R&D of $94.3M in Q2 2026.
- How has Bruker's R&D changed year-over-year?
- Bruker's R&D decreased by 5.9% year-over-year, from $100.2M to $94.3M.
- What is the long-term trend for Bruker's R&D?
- Over 4 years (2021 to 2025), Bruker's R&D has grown at a 15.7% compound annual growth rate (CAGR), from $220.8M to $395.2M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Bruker's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude